Anika Therapeutics ANIK FX Effect on Cash
FX Effect on Cash at other companies
Other financials
Where this comes from
Reported directly by Anika Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.
The official record: Anika Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Anika Therapeutics's fx effect on cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Anika Therapeutics's FX effect on cash?
- Anika Therapeutics (ANIK) reported FX effect on cash of -$29K in Q1 2026.
- How has Anika Therapeutics's FX effect on cash changed year-over-year?
- Anika Therapeutics's FX effect on cash decreased by 126.9% year-over-year, from $108K to -$29K.
- What does FX effect on cash mean?
- The impact of exchange rate changes on the value of cash and equivalents held in foreign currencies.